Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Mike Ankley who wrote (3022)	7/12/1998 10:04:00 AM
From: Mr. Forthright	Respond to of 5402

Does that mean that SGNC should have a product approved in less than 10 years?

To: Mike Ankley who wrote (3022)	7/12/1998 1:59:00 PM
From: Prospector	Read Replies (1) \| Respond to of 5402

Application ..........U.S.market size........... market Transfusion..........$ 3.5 Billion..................40% Heart Attack.......... $ 1.4 Billion ..................11% Srtoke................. $ 620 Million ...............5% Cancer..................$ 300 Million ................5% NMR ......................$180 Million .................8% X-RAY ....................$ 175 Million .................11% OTHER .....................$1.2 Billion ................20% Prospector